Astera Labs (NASDAQ:ALAB) Trading Down 11.4% Following Insider Selling

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were down 11.4% during mid-day trading on Friday following insider selling activity. The stock traded as low as $314.84 and last traded at $317.06. Approximately 7,269,806 shares changed hands during trading, an increase of 31% from the average daily volume of 5,546,471 shares. The stock had previously closed at $358.05.

Specifically, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $3,276,963.90. Following the sale, the director directly owned 5,292 shares of the company’s stock, valued at approximately $1,928,140.20. This trade represents a 62.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the sale, the director directly owned 60,134 shares in the company, valued at $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Roth Mkm reaffirmed a “buy” rating and set a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada upped their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Stock Performance

The stock has a fifty day simple moving average of $212.95 and a two-hundred day simple moving average of $171.60. The stock has a market capitalization of $54.35 billion, a price-to-earnings ratio of 214.23, a P/E/G ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the firm earned $0.33 EPS. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently bought and sold shares of the business. Assetmark Inc. boosted its position in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Reflection Asset Management purchased a new position in shares of Astera Labs during the fourth quarter worth approximately $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank increased its stake in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Finally, Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the 4th quarter valued at about $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.